Top brokerage firms like Macquarie maintained an outperform rating on Aurobindo Pharma, raising the target price to Rs 1,385. Aurobindo Pharma signed a master service agreement with Merck Sharp & Dohme, leading to a biologics CMO contract with TheraNym.
NSE increases lot sizes for all 5 index derivative contracts after Sebi order
The new measure will take effect from November 20, 2024, for all newly introduced index derivatives contracts, including weekly, monthly, quarterly, and half-yearly, according to
October 19, 2024